Covered Stocks

Jonathan Wolleben

Work

Analyst Jonathan Wolleben works at JMP and is focused on the Healthcare sector with 50 price targets and ratings documented since 2019 spanning on 9 stocks. Analyst's average stock valuation to be materialised ratio is 5% with an average time for price targets to be met of 184.5 days.

Most recent stock forecast was given on ALT, Altimmune, Inc at 11-Nov-2022.

Jonathan Wolleben best performing recommendations are on OCUL (OCULAR THERAPEUTIX, INC).
The best stock recommendation documented was for OCUL (OCULAR THERAPEUTIX, INC) at 9/29/2020. The price target of $16 was fulfilled within 57 days with a profit of $8.19 (104.87%) receiving and performance score of 18.4.

Average potential price target upside

ALT CLSD CRNX DBVT LRMR OCUL PRQR BCRX RLYB
ALT CLSD CRNX DBVT LRMR OCUL PRQR BCRX RLYB